| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8233710 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 6 Pages |
Abstract
Our results from SEER show that PORT for T/TC had no advantage in patients with LOC disease (Masaoka Stage I), but a possible OS benefit of PORT in patients with REG disease (Masaoka Stage II-III) was found, especially after non-extirpative surgery. The role of PORT in T/TC needs further evaluation.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jeffrey A. M.D., Nan Ph.D., M.P.H., Achilles J. M.D., Patrick J. M.D., Peter A.S. M.D., F.A.C.R.,